Device Surgical Stapling

Eea

Payments companies reported to CMS as associated with Eea. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$49Kassociated payments (2023-2025)

560clinicians with associated payments

1company reporting

By year

2023 $20K

2024 $14K

2025 $15K

Payments reported as associated with Eea, per program year, as reported to CMS.

Who makes it

Medtronic, INC. $49K associated with Eea (2023-2025)

Specialties most often involved

Surgery $17K

Colon & Rectal Surgery $14K

Gastroenterology (Internal Medicine) $1,756

Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,659

Physician Assistant $1,163

Surgical Oncology $934

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Eea

These are the largest totals companies reported as associated with Eea. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
David Rosen	Cleveland, OH	Colon & Rectal Surgery	$729.61
Oleg Orlov	Milton, MA		$710.93
William Kastrinakis	Danvers, MA	Surgery	$649.05
Katherine Garcia	Fairview Park, OH	Nurse Practitioner	$630.78
Jean Carrasquillo	Mayaguez, PR	Surgery	$541.39
Fernando Martinez Colon	Hato Rey, PR	Colon & Rectal Surgery	$541.36
Paul Cavallaro	Tampa, FL	Surgery	$535.44
Jonathan Umbel	Westlake, OH	Gastroenterology (Internal Medicine)	$505.80
Brian Haines	Cleveland, OH	Hematology & Oncology	$505.80
Jorge Marcet	Tampa, FL	Colon & Rectal Surgery	$451.24

Prescribed Eea?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.